Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Anke

Anke Abken, Toledo, OH US

Patent application numberDescriptionPublished
20090194166PHOTOVOLTAIC DEVICES INCLUDING DOPED SEMICONDUCTOR FILMS - A photovoltaic cell can include a dopant in contact with a semiconductor layer.08-06-2009
20090255578Plasma-treated photovoltaic devices - A method of manufacturing a thin film photovoltaic device includes depositing a first compound semiconductor layer on a substrate and exposing the device to plasma, the plasma treating the layer.10-15-2009

Anke Abken, Whitehouse, OH US

Patent application numberDescriptionPublished
20100212731Photovoltaic Devices Including Controlled Copper Uptake - A photovoltaic cell can include a substrate having a copper-doped semiconductor layer. The doping can be mediated with a salt.08-26-2010
20100307561DOPED METAL CONTACT - A photovoltaic device can include a second metal layer adjacent to a first layer, where the first layer is positioned adjacent to a substrate, and where the second metal layer includes a dopant; and a copper-indium-gallium diselenide (CIGS) layer adjacent to the second metal layer.12-09-2010
20100307568METAL BARRIER-DOPED METAL CONTACT LAYER - A photovoltaic device can include an intrinsic metal layer adjacent to a semiconductor absorber layer; and a doped metal contact layer adjacent to the intrinsic metal layer, where the doped metal contact layer includes a metal base material and a dopant.12-09-2010
20100326491DOPANT-CONTAINING CONTACT MATERIAL - A photovoltaic device can include a doped contact layer adjacent to a semiconductor absorber layer, where the doped contact layer includes a metal base material and a dopant.12-30-2010
20110136294Plasma-Treated Photovoltaic Devices - A method of manufacturing a thin film photovoltaic device includes depositing a first compound semiconductor layer on a substrate and exposing the device to plasma, the plasma treating the layer.06-09-2011

Anke Allwardt, Beckenried CH

Patent application numberDescriptionPublished
20100133046ELEVATOR SYSTEM, SUSPENSION ELEMENT FOR AN ELEVATOR SYSTEM, AND DEVICE FOR MANUFACTURING A SUSPENSION ELEMENT - An elevator system with a car or platform to transport passengers and/or goods as well as with a counterweight, which are arranged as traversable or movable along a travel path, and which are coupled and/or with a drive by a suspension element interrelating their motion. The suspension element is guided and/or driven by a traction sheave and/or a drive shaft and/or a deflecting pulley. The suspension element is sheathed and/or belt-type, with a first layer made of a first plasticizable and/or elastomeric material, containing a first exterior surface, and with at least one tension member—rope-type, tissue-type, or comprising a multitude of partial elements—that is embedded in the first layer of the suspension element. A manufacturing procedure for one of the suspension elements is provided.06-03-2010

Anke Beselin, Mulheim DE

Patent application numberDescriptionPublished
20090104657Lipase Production Method - The invention relates to novel proteins, especially with protease activity, which promote the production of extracellular lipases by bacteria, especially of the genus 04-23-2009

Anke Blaul, Darmstadt DE

Patent application numberDescriptionPublished
20110088589Anticorrosion additives for manufacturing processes, a process for preparation thereof and use thereof - The present invention relates to novel anticorrosion additives for manufacturing processes, comprising at least one triazole and the reaction product of at least one alkylene glycol and at least one carboxylic anhydride, to a process for preparation thereof and to the use thereof for corrosion protection for aluminium and/or aluminium alloys.04-21-2011
20120071595Novel aqueous resorcinol-formaldehyde-latex dispersions, adhesion-improved fibres, processes for production thereof and use thereof - The present invention relates to novel aqueous resorcinol-formaldehyde-latex dispersion, to adhesion-improved fibres, to processes for production thereof, and to use thereof for improving adhesion in tyres.03-22-2012
20120074358Anticorrosion additives for manufacturing processes, a process for preparation thereof and use thereof - The present invention relates to novel anticorrosion additives for manufacturing processes, comprising at least one triazole and the reaction product of at least one alkylene glycol and at least one carboxylic anhydride, to a process for preparation thereof and to the use thereof for corrosion protection for aluminium and/or aluminium alloys.03-29-2012

Anke BrÖnstrup, Weesen CH

Patent application numberDescriptionPublished
20110284364Aluminum Doped Zinc Oxide Sputtering Targets - A sputtering target precursor material comprises a homogeneous distribution of a ZnAl11-24-2011

Anke Buchholz, Stein CH

Patent application numberDescriptionPublished
20100267563METHOD OF IMPROVING THE GROWTH OF A PLANT - A method of improving the growth of a plant comprising applying to a plant, plant propagation material or locus thereof a composition comprising a product, which comprises microcapsules which themselves comprise (a) a polymeric shell; and (b) a core which comprises a dispersed solid active ingredient compound wherein the compound is one or more of a neonicotinoid, fipronil, a strobilurin, carboxin, acibenzolar-S-methyl, and probenazole.10-21-2010

Anke Burger-Kentischer, Stuttgart DE

Patent application numberDescriptionPublished
20090253134Cellular Pyrogen Test - The invention concerns methods, agents and kits for qualitative and quantitative detection and identification of pathogens and pathogen spectra based on endotoxins and other pyrogens.10-08-2009
20110300530IN VITRO TEST SYSTEM FOR VIRAL INFECTIONS - The invention relates to a multi-layered biological in vitro tissue containing: dermis layer, containing a collagen biomatrix with fibroblasts embedded therein and epidermis layer, containing epithelial cells. It is provided that latently virally infected neuronal cells are integrated at least into the dermis layer.12-08-2011

Anke Esperester, Mainz DE

Patent application numberDescriptionPublished
20080319087Use of Ambroxol for the Treatment of Rhinovirus Infections - The invention is directed to the use of ambroxol or pharmaceutically acceptable salts thereof for preparing a medical composition for treating or preventing infections caused by human rhinovirus. Surprisingly it was found that Ambroxol is capable to suppress the replication of human rhinovirus. Therefore, the ambroxol-containing medical composition is suitable to treat or prevent against all symptoms of a rhinovirus infection and provides a direct antivirale effect.12-25-2008
20100330176Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity - The invention relates to the use of ambroxol and the pharmacologically acceptable salts thereof for preparing a pharmaceutical composition for the treatment of painful conditions in the oral and pharyngeal cavity.12-30-2010
20110053874USE OF FLAVONOIDE COMPOUNDS FOR THE PROPHYLAXIS AND THERAPY OF ISCHAEMIC OR INFLAMMATORY HEART AND CARDIOVASCULAR DISEASES - The present invention relates to the use of flavonoid compounds, particularly quercetin-3-O-β-D-glucuronide and kaempferol-3-O-β-D-glucuronide and their glucosides, for preventing diseases of the heart. Red vine leaf extract has proved a particularly advantageous source of the flavonoid compounds in question.03-03-2011
20110129809METHODS FOR THE ANTI-INFLAMMATORY AND ANTI-EDEMATOUS PROTECTION OF EXPLANTED BIOLOGICAL MATERIAL UNTIL THE TRANSPLANTATION THEREOF IN PATIENTS - The invention relates to a method for protecting transplants, as well as organs and individual blood vessels, against inflammatory reactions that are caused by the operative procedure linked to the explantation and storage until transplantation. This can be achieved by treating the transplant via intra arterial application of flavonol compounds, in particular with quercetin glucuronide and/or kaempferol glucuronide.06-02-2011

Patent applications by Anke Esperester, Mainz DE

Anke Frohberger, Heidelberg DE

Patent application numberDescriptionPublished
20100017032DEVICE FOR CONTROLLING A ROBOT - A device is disclosed for controlling a robot, with a robot control unit, and with a robot sensor such as a digital camera, which can be fitted on the robot and whose output signals can be supplied to an image recording unit. The output signals from the image recording unit connected to the camera can be supplied to an image processing device which is connected to the image recording unit. A coordinate transformation device is provided, in which the signals originating from the image processing unit and the robot control unit are processed and transformed into robot control signals, and the signals can be supplied back to the robot control unit.01-21-2010

Anke Hasenkox, Viersen DE

Patent application numberDescriptionPublished
20120024135MORTAR - A mortar includes at least one barrel mounted movably over a ball journal in a bottom supporting device, and an aiming device serving to aim the barrel vertically and horizontally. In order to be able to aim the barrel of the mortar automatically in a simple and cost advantageous manner, the aiming device preferably comprises a carriage that can be moved along guideways essentially horizontally towards or away from the barrel. At the carriage, the first end region of a pivoted arm is mounted so that it can be rotated about a pivot axis, and the second end region of the pivoted arm is connected with a spherical plain bearing, guiding the barrel. The spherical plain bearing embraces a housing part, which is open at its end faces and in which an inner part is mounted spherically (rotatably), which contains a cylindrical barrel guide, for movably accommodating the barrel.02-02-2012

Anke Heidbrede, Mannheim DE

Patent application numberDescriptionPublished
20090156423METHOD AND DEVICE FOR INTEGRATED SYNTHESIS AND ANALYSIS OF ANALYTES ON A SUPPORT - Methods and devices provide integrated synthesis of a support for analyte determination and the analyte determination. Preferred embodiments involve particles immobilized on the surface of a support to which receptors are coupled location-specifically, time-specifically or both on pre-determined positions on the support.06-18-2009

Anke Heimburg, Magdeburg DE

Patent application numberDescriptionPublished
20120028995NOVEL COMPOUNDS FOR MEDICAL USE AS PEPTIDASE EFFECTORS - The invention relates to compounds of general formula (I) as set forth in the claims as well as to the use of the compounds of the general formula (1) in the medical field, specifically for use in the suppression of DNA synthesis and inflammatory cytokine production as well as in the stimulation of anti-inflammatory cytokine production in vitro and in vivo. This abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.02-02-2012

Anke Homann-Wischinski, Langenfeld DE

Patent application numberDescriptionPublished
20110076751LYSIS, BINDING AND/OR WASH REAGENT FOR ISOLATING AND/OR PURIFYING NUCLEIC ACIDS - The present invention relates to a lysis, binding and/or wash reagent for isolating and/or purifying nucleic acids and a method for isolating and/or purifying nucleic acids.03-31-2011

Anke Jaudszus, Mechterstaedt DE

Patent application numberDescriptionPublished
20090118369Use of CIS-9, Trans-11 Isomer of Conjugated Lineoleic Acid - A composition and medicament comprising the cis-9, trans-11 isomer of conjugated linoleic acid for treating inflammatory diseases, including asthma, is provided. A method for inhibiting the proliferation of human or animal cells of the immune systems involved in an immune response including administering the cis-9, trans-11 isomer of conjugated linoleic acid to a patient is also provided. A nutritional, functional food, or dietary supplement including the cis-9, trans-11 isomer of conjugated linoleic acid is also provided.05-07-2009

Anke Jedrkowiak, Markgroeningen DE

Patent application numberDescriptionPublished
20120059284STATUS DETECTING DEVICE TO BE ATTACHED TO A LIVING BEING - A status detecting device is described for being attached to a living being, in particular a person, to detect the position of the body of the living being, having a first sensor, configured as an acceleration sensor and/or a gyroscopic sensor. An additional, second sensor, configured as a height measuring sensor, is also provided. Also described is a corresponding method.03-08-2012

Anke Jung, Bayreuth DE

Patent application numberDescriptionPublished
20090117803PLEATABLE NONWOVEN MATERIAL AND METHOD AND APPARATUS FOR PRODUCTION THEREOF - A pleatable nonwoven material is provided, including thicker form-giving fibers and thinner fibers determining the filter effect, wherein the thinner fibers are incorporated largely homogeneously in the thicker fibers running in the direction along the surface of the nonwoven material and a distribution density gradient of the thinner fibers is established perpendicular to the surface of the nonwoven material such that the highest concentration of thinner fibers is in the region of the center or on one of the two outsides, wherein the thicker and thinner fibers are bonded together by solidification from the melted condition and are made from the same material.05-07-2009

Anke Klippel-Giese, Park Ridge, NJ US

Patent application numberDescriptionPublished
20110008320Further Use of Protein Kinase N Beta - The present invention is related to use of protein kinase N beta or a fragment or derivative thereof as a downstream target of the PI 3-kinase pathway, preferably as a downstream drug target of the PI 3-kinase pathway.01-13-2011

Anke Klippel-Giese, Berlin DE

Patent application numberDescriptionPublished
20090186845INTERFERING RNA MOLECULES - The present invention is related to a ribonucleic acid comprising a double stranded structure whereby the double-stranded structure comprises a first strand and a second strand, whereby the first strand comprises a first stretch of contiguous nucleotides and whereby said first stretch is at least partially complementary to a target nucleic acid, and the second strand comprises a second stretch of contiguous nucleotides whereby said second stretch is at least partially identical to a target nucleic acid, and whereby the double stranded structure is blunt ended.07-23-2009
20100285038Factor Involved in Metastasis and Uses Thereof - The present invention is related to a nucleic acid coding for a factor involved in a biological process, whereby the process is a PI 3-kinase pathway regulated process, preferably a process selected from the group comprising glucose metabolism, amino acid and glucose deprivation processes, diabetes, wound healing, stress response, apoptosis, metastasis, tumorigenesis, cell migration, cell motility in extracellular matrix and cell growth in extracellular matrix, and the factor is a polypeptide comprising an amino acid sequence according to SEQ ID. NO. 1 or a polypeptide having a sequence according to databank entries gi 9506687 or NP_061931, preferably NP_061931.1.11-11-2010
20110118456Interfering RNA Molecules - The present invention is related to a ribonucleic acid comprising a double stranded structure whereby the double-stranded structure comprises a first strand and a second strand, whereby the first strand comprises a first stretch of contiguous nucleotides and whereby said first stretch is at least partially complementary to a target nucleic acid, and the second strand comprises a second stretch of contiguous nucleotides whereby said second stretch is at least partially identical to a target nucleic acid, and whereby the double stranded structure is blunt ended.05-19-2011

Patent applications by Anke Klippel-Giese, Berlin DE

Anke Kretz-Rommel, San Deigo, CA US

Patent application numberDescriptionPublished
20100105620Polypeptides that bind Trail-R1 and Trail-R2 - Agonists for TRAIL death receptors including polypeptides having a multimerizing, e.g. trimerizing, domain and a polypeptide sequence that binds to at least one of TRAIL death receptors TRAIL-R1 and TRAIL-R2. Agonists are described that do not bind to TRAIL decoy receptors. The multimerizing domain may be derived from human tetranectin. The agonists can induce apoptosis in pathogenic cells expressing a TRAIL death receptor. Pharmaceutical compositions are described for treating diseases associated with cells expressing DR4 and DR5, such as tumor cells. Methods for selecting polypeptides and preparing multimeric complexes.04-29-2010

Anke Küdde, Guentersleben DE

Patent application numberDescriptionPublished
20110318495AQUEOUS COATING MATERIAL, ITS PREPARATION AND USE - The present invention relates to an aqueous coating material comprising at least one ionically and/or nonionically stabilized polyurethane, which is saturated, unsaturated and/or grafted with olefinically unsaturated compounds, and at least one organic, aliphatic solvent, wherein said solvent has a solubility parameter δ<10 (cal/cm12-29-2011

Anke Küdde, Güntersleben DE

Patent application numberDescriptionPublished
20090209701WATER-BASED LACQUERS COMPRISING HIGHLY FUNCTIONAL, HIGHLY BRANCHED OR HYPERBRANCHED POLYCARBONATES - The present invention relates to aqueous basecoat materials which comprise high-functionality, highly branched or hyperbranched polycarbonates based on dialkyl or diaryl carbonates or on phosgene, diphosgene or triphosgene and on aliphatic, aliphatic/aromatic or aromatic diols or polyols.08-20-2009

Anke Küdde, Güntersleben DE

Patent application numberDescriptionPublished
20090209701WATER-BASED LACQUERS COMPRISING HIGHLY FUNCTIONAL, HIGHLY BRANCHED OR HYPERBRANCHED POLYCARBONATES - The present invention relates to aqueous basecoat materials which comprise high-functionality, highly branched or hyperbranched polycarbonates based on dialkyl or diaryl carbonates or on phosgene, diphosgene or triphosgene and on aliphatic, aliphatic/aromatic or aromatic diols or polyols.08-20-2009

Anke Luedge, Schulzendorf DE

Patent application numberDescriptionPublished
20090068407METHOD FOR PRODUCING A MONOCRYSTALLINE SI WAFER HAVING AN APPROXIMATELY POLYGONAL CROSS-SECTION AND CORRESPONDING MONOCRYSTALLINE SI WAFER - A method of making a single-crystalline Si wafer with an approximately polygonal cross section and having a material property that is the same as a zone-pulled Si crystal, and the single-crystalline Si wafer. The method includes pulling at least one bottle neck of a crystal vertically downwards from a rotating hanging melt drop. The rotational speed of the crystal is reduced to between 0 and less than 1 rpm. In a crystal-growth phase, a Si single crystal ingot is pulled vertically downwards with an approximately polygonal cross section. An inductor is used to generate a temperature profile at a growth phase boundary of the crystal that corresponds to the shape of a cross section of the pulled Si single crystal ingot. The growth is ended at a desired pulling length and the Si single crystal ingot is cut into wafers having an approximately polygonal cross section.03-12-2009

Anke Mayer-Bartschmid, Wulfrath DE

Patent application numberDescriptionPublished
20110015248SUBSTITUTED HETEROCYCLES - The present invention relates to substituted heterocycles, processes for their preparation, and their use in medicaments, especially for the treatment of inflammatory disease, i.e. asthma, or cancer.01-20-2011

Patent applications by Anke Mayer-Bartschmid, Wulfrath DE

Anke Mayer-Bartschmid, Wuelfrath DE

Patent application numberDescriptionPublished
20090252804MEDICAL DEVICES WITH AN ANTIBACTERIAL POLYURETHANEUREA COATING - The present invention relates to a medical device which has at least one coating which is obtained starting from an aqueous dispersion, the aqueous dispersion comprising at least one nonionically stabilized polyurethaneurea and at least one silver-containing constituent.10-08-2009
20090253848AQUEOUS SILVER-CONTAINING NONIONIC POLYURETHANE DISPERSIONS - The present invention relates to an aqueous dispersion comprising at least one nonionically stabilized polyurethaneurea and at least one silver-containing constituent.10-08-2009

Anke Mueller, Germering DE

Patent application numberDescriptionPublished
20100184789INHIBITORS OF PROTEIN KINASES - The present invention relates to inhibitors of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to methods of preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases comprising the administration of an effective amount of at least one inhibitor of cyclin-dependent kinases.07-22-2010
201103066024, 6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES - The present invention relates to inhibitors of general Formula (I) of cyclin-dependent kinases and therapeutic applications thereof. Furthermore, the invention relates to compounds for preventing and/or treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases.12-15-2011

Anke Müller, Germering DE

Patent application numberDescriptionPublished
20100249149Inhibitors of Protein Kinases - are useful as inhibitors of cyclin dependent kinases such as CDK9.09-30-2010

Anke Müller, Germering DE

Patent application numberDescriptionPublished
20100249149Inhibitors of Protein Kinases - are useful as inhibitors of cyclin dependent kinases such as CDK9.09-30-2010

Anke Rattenholl, Halle DE

Patent application numberDescriptionPublished
20100203589METHOD FOR OBTAINING ACTIVE BETA-NGF - The invention relates to a method for producing biologically active β-NGF from the proform proNGF. After expressing the proform of the β-NGF in a prokaryotic host cell, the recombinant protein is isolated in the form of insoluble inactive aggregates (inclusion bodies). After the solubilization thereof in a strong denaturing agent and the subsequent conversion thereof into the natural conformation, which is determined by the disulfide bridges present in the natural β-NGF, biologically active β-NGF is obtained by subsequently splitting-off the prosequence.08-12-2010

Anke Reinschmidt, Macungie, PA US

Patent application numberDescriptionPublished
20120077906Flexible Watertight Roof Coatings - The invention provides for the use of coating compositions based on one or more mineral binders, one or more polymers, one or more fillers, and, if desired, one or more additives for producing roof coatings, the coating compositions comprising at least 50% by weight of polymers, based on the dry weight of the polymers and of the mineral binders.03-29-2012

Anke Richter, Munchen DE

Patent application numberDescriptionPublished
20080276198Method for Controlling a Device - A device with a graphical user interface, via which the functions of the device are controlled has functions divided into categories which are sub-divided into subcategories. The categories are represented by primary regions that are schematically arranged on the user interface. The primary regions contain elements, each of which represents a sub-category of the category of the respective primary region. In addition, only one primary region is expanded by the display of a secondary region after an element has been selected. The secondary region contains control elements for at least one function that is assigned to the sub-category representing the selected element. The at least one function is controlled by the control elements.11-06-2008

Anke Robeller, Boeblingen DE

Patent application numberDescriptionPublished
20090178041Method for Counting Events - The invention relates to a method for counting events in an information technology system which performs one or more threads of executions, wherein an event counter is introduced comprising: 07-09-2009

Anke Traebert, Stuttgart DE

Patent application numberDescriptionPublished
20110005199Method for Reducing Emission of Nitrogen Oxide in a Motor Vehicle Having a Lean Burning Internal Combustion Engine - In a method for reducing the emission of nitrogen dioxide in a motor vehicle having an exhaust gas purification system having an SCR catalytic converter with adsorption centers for nitrogen oxides, an exhaust gas enriched with ammonia is supplied to the SCR catalytic converter above an operating temperature. Below the operating temperature, the exhaust gas supplied to the SCR catalytic converter is enriched with a material such that an adsorption of nitrogen oxides is inhibited at corresponding adsorption centers of the SCR catalytic converter. In order to reduce the overall NO01-13-2011
20120004825Method for the Operation of an Internal Combustion Engine Comprising an Emission Control System that Includes an SCR Catalyst - A method for operating an internal combustion engine comprising an exhaust gas cleaning system that includes a SCR catalyst. In conjunction with a cold start and/or a warm-up of the internal combustion engine, the internal combustion engine is operated using a cold start engine operation method having predefineable values for predefineable operating parameters of the internal combustion engine. An amount of nitrogen oxides stored in the SCR catalyst is estimated, and the cold start engine operation method is activated when the estimation indicates that the nitrogen oxide storage amount exceeds a predefineable nitrogen oxide storage amount limit value.01-05-2012
20120004833Method for Operating an Internal Combustion Engine with an Emission Control System - A method for operating an internal combustion engine comprising an emission control system that includes at least one catalytic and/or filter-effective emission control component. In conjunction with a cold start and/or a warm-up of the internal combustion engine, the internal combustion engine is operated using a cold start engine operation process having predefined values for predefined operating parameters of the internal combustion engine. An amount of hydrocarbons (HC) stored in one or more of the at least one emission control component is estimated, and the cold start engine operation process is activated when the estimation indicates that the amount of stored HC exceeds a predefined maximum amount of stored HC.01-05-2012

Anke Tusche, Rietschen DE

Patent application numberDescriptionPublished
20110318818STRAW FOR THE CONSERVATION OF A PREDETERMINED DOSE OF A LIQUID BASE SUBSTANCE, IN PARTICULAR A BIOLOGICAL SUBSTANCE - The straw comprises a tube (12-29-2011

Anke Vogelgsang, Goettingen DE

Patent application numberDescriptionPublished
20080247050MICROSCOPE OBJECTIVE - The invention relates to a microscope objective which consists of at least four lenses or groups of lenses and can preferably be used to improve image contrast.10-09-2008

Anke Woestemeyer, Jena DE

Patent application numberDescriptionPublished
20080207461Devices for Conducting and Analyzing Microarray Experiments - The present invention relates to devices for the simultaneous performance of microarray experiments for detecting specific interactions between probe and target molecules in a microtiter plate as well as to methods for manufacturing such devices. Furthermore, the present invention relates to the use of such devices in a method for qualitatively and/or quantitatively detecting specific interactions between probe and target molecules.08-28-2008

Anke Wolf, Rio De Janeiro BR

Patent application numberDescriptionPublished
20100263357THREE WAY CATALYST - A double-layer three-way catalyst for purification of the exhaust gases from internal combustion engines which has excellent activity and thermal stability is described. The catalyst contains active aluminium oxide and a first cerium/zirconium mixed oxide which are both catalytically activated with palladium in the first layer applied to a catalyst support. In the second layer which is in direct contact with the exhaust gas, the catalyst likewise contains an active aluminium oxide and a second cerium/zirconium mixed oxide which are both catalytically activated with rhodium. The second cerium/zirconium mixed oxide has a higher zirconium oxide content than the first mixed oxide.10-21-2010

Anke Wostemeyer, Jena DE

Patent application numberDescriptionPublished
20120058464Assay Methods Using Array of Test Zones - A method for assaying a sample for each of multiple analytes is described. The method includes contacting an array of spaced-apart test zones with a liquid sample (e.g., whole blood). The test zones disposed within a channel of a microfluidic device. The channel is defined by at least one flexible wall and a second wall which may or may not be flexible. Each test zone comprising a probe compound specific for a respective target analyte. The microfluidic device is compressed to reduce the thickness of the channel, which is the distance between the inner surfaces of the walls within the channel. The presence of each analyte is determined by optically detecting an interaction at each of multiple test zones for which the distance between the inner surfaces at the corresponding location is reduced. The interaction at each test zone is indicative of the presence in the sample of a target analyte. Capillary structures of the devices or used in the methods may comprise a matrix and the devices may comprise control elements and methods for assaying of sample may use corresponding controlling activities.03-08-2012

Anke Wöstemeyer, Jena DE

Patent application numberDescriptionPublished
20110124114Assays - A method for assaying a sample for each of multiple analytes is described. The method includes contacting an array of spaced-apart test zones with a liquid sample (e.g., whole blood). The test zones disposed within a channel of a microfluidic device. The channel is defined by at least one flexible wall and a second wall which may or may not be flexible. Each test zone comprising a probe compound specific for a respective target analyte. The microfluidic device is compressed to reduce the thickness of the channel, which is the distance between the inner surfaces of the walls within the channel. The presence of each analyte is determined by optically detecting an interaction at each of multiple test zones for which the distance between the inner surfaces at the corresponding location is reduced. The interaction at each test zone is indicative of the presence in the sample of a target analyte. Capillary structures of the devices or used in the methods may comprise a matrix and the devices may comprise control elements and methods for assaying of sample may use corresponding controlling activities.05-26-2011

Anke Zobywalski, Griesheim DE

Patent application numberDescriptionPublished
20100284976COMPOSITIONS FOR THE PREPARATION OF MATURE DENDRITIC CELLS - The invention relates to a method for in vitro maturation of at least one immature dendritic cell, comprising stimulating said immature dendritic cell with TNFα, IL-1β, IFNγ, a TLR7/8 agonist and prostaglandin E2 (PG). Furthermore, the invention relates to a composition comprising said factors as well as to mature dendritic cells produced by the method of the invention.11-11-2010